FDA Investigator Ruth A Williams

Ruth A Williams has inspections in 5 countries as of 14 Sep 2023. Ruth A Williams has collaborated with a combinined 2314 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Netherlands, Germany, Denmark, United Kingdom of Great Britain and Northern Ireland
Aaron F Coleman, Addam S Reynolds, Alanna Lmussawwir Bias, Alberto A Viciedo, Alexander B Anderson, Angela F Orozco, Angela Shepas, Anna Kevilag, Anna Kwilas, Arie C Menachem, Barbara J White, Benita C Okeke, Bichsa T Tran, Brunilda Torres, Carla R Hinz, Carolyn J Cook, Cheryl A Grandinetti, Christin L Torres, Christine I Shaw, Courtney R Bratina, Craig A Garmendia, Cynthia Jim, CSO, Daniel Pst Laurent, Dawn C Olenjack, Dawn L Wydner, Dawn M Mccabe, Deborah S Hammond, Diane Cvan Leeuwen, Dianiris C Ayala, Doan T Nguyen, PharmD, Dorothy J Denes, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Earl Echon, Eduardo Carbonell, Edward D Harris, Edwards, Edwin J Gorney, Emily A Baldwin, Emily A Walters, Erin D Mccaffery, Erin M Mcdowell, Erin Mcdowell, Gabriel E Muniz, George A Prager, Ginger M Sykes, Gloria A Milster, Haley H Seymour, Hanna L Potter, Heather M Bullock, Hector J Colon Torres, Helen B Ricalde, Hong Song, Hugh M Mcclure, II, Hunt, Ismael Olvera, IV, Jacob W Reynolds, James To Neal, Jamie L Dion, Jason P Aun, Jeanne J Thai, Jennifer L Huntington, Jennifer Lalama, Joanne E King, John J Bernal, Jonathan R Campos, Joo Jin, Jose Acruz Gonzalez, Jose M Cayuela, Jose Perez Soto, Joshua J Silvestri, Justine Tomasso, Karen M Rodriguez, Kathleen S Tormey, Keith A Schwartz, Kelly D Moore, Kelly M Byers, Kent C Faul, Kimberly L Schultz, Ladislav Kermet, Lavender M Huskey, LCDR Angelica M Chica, LCDR Randall L Morris, Leighton K Ngai, Leslin M Coachman, Linda K Matheny, Linda M Cheny, Linda Thai, Lissette Paiz, LT Richard A Lyght, Luz I Collado, Margaret M Sands, Marinee Flores Marrero, Marion W Nadeau, Matthew F Duff, Megan K Otero, Melissa T Roy, Meredith M Cobb, Michael C Lombardi, Michael D Garcia, Michael R Goga, Michael Serrano, Michelle A Marsh, Michelle M Noe Varga, Nathan R Moon, Nicholas A Violand, Nicole M Bell, Nimmy Mathews, Nina Yang, Ormond, Peter R Lenahan, Randy V Bong, Reynolds, Rina Bhikha, Robert W Calais, Shari H Shambaugh, Sheri L Stephenson, Stacey L Witherwax, State Agency, Stefanie R Cook, Stephen T Hansen, Suzanne A Lovelady, Teena H Aiken, Teresa I Navas, Theressa B Smith, Thomas P Hansen, Trinidad D Barreras, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Victor Spanioli, Virgilio F Pacio, CSO

Ruth A Williams's Documents

Publish Date Document Type Title
April, 2023 FDA 483 John F. Foley, MD - Form 483, 2023-04-21
August, 2022 FDA 483 Khaled Tawansy, MD - Form 483, 2022-08-24
December, 2020 FDA 483 James K. Luu, MD - Form 483, 2020-12-18
March, 2017 FDA 483 Julio Tallet, MD - Form 483, 2017-03-29
May, 2019 FDA 483 Response Michael W. Harris, D.O. - Form 483R, 2019-06-12
September, 2019 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2019-09-13
May, 2017 FDA 483 Victor L. Perez, M.D. - Form 483, 2017-05-22
September, 2020 FDA 483 Michael J. Schurr, MD - Form 483, 2020-09-14
November, 2020 FDA 483 Marcello M. Rotta, MD - Form 483, 2020-11-23
May, 2019 FDA 483 Michael W. Harris, D.O. - Form 483, 2019-05-24
August, 2019 FDA 483 Christopher C. Canale, M.D. - Form 483, 2019-08-02
January, 2020 FDA 483 Ehrin J. Armstrong, MD - Form 483, 2020-01-23
July, 2016 FDA 483 Linfritz Research Institute Inc. - Form 483, 2016-07-22
July, 2018 FDA 483 Catalyst Pharmaceuticals, Inc. - Form 483, 2018-07-27
March, 2020 FDA 483 National Jewish Health - Form 483, 2020-03-09
June, 2018 EIR CELGENE CORPORATION - EIR, 2018-06-27
June, 2016 FDA 483 Nova Southeastern University IRB #1 - Form 483, 2016-06-16
September, 2019 EIR Lovelace Biomedical Research Institute - EIR, 2019-09-13
October, 2019 FDA 483 Alan E. Kimura, M.D. - Form 483, 2019-10-04
March, 2020 EIR National Jewish Health - EIR, 2020-03-09
June, 2017 FDA 483 Department of Veterans Affairs Medical Center - Form 483, 2017-06-16
May, 2017 EIR Victor L. Perez, M.D. - EIR, 2017-05-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more